bioMérieux S.A. (BMXMF)

R&D to Revenue

12.47%

Fiscal year · Period ending:

BMXMF logo

BMXMF R&D to Revenue

Latest reported12.47%
BMXMF FY R&D/Revenue (13.15% → 12.47%)
High-resolution chart · PNG

BMXMF r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

bioMérieux S.A. R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
12.4674%
12.3496%
12.5207%
12.4432%
11.427%
12.69%
13.9263%
15.1861%
13.303%
12.9279%
12.1602%
12.1173%
12.0788%
10.8931%
10.6572%
10.9948%
11.6887%
11.9496%
12.4012%
12.4988%
13.1542%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.